1. UN. Report of the International Conference on Population and Development, Cairo, 5-13 September 1994. New York: United Nations, 1995: Sales No. 95.XIII.18.
2. WHO. Reproductive health strategy to accelerate progress towards the attainment of international development goals and targets. Genova: Organización Mundial de la Salud, 2004.
3. UN. Key actions for the further implementation of the Programme of Action of the International Conference on Population and Development. New York: United Nations, 1999: A/S-21/5Add.1.
4. UN. United Nations Millennium Declaration. New York: United Nations, 2000: A/RES/55/2, Section II.
5. UN. Road map towards the implementation of the United Nations Millennium Declaration. New York: United Nations, 2001: A/56/326.
6. UN Millennium Project. Investing in development: a practical plan to achieve the Millennium Development Goals. New York: United Nations Development Programme, 2005.
7. UN. 2005 World summit outcome. New York: United Nations, 2005: A/RES/60/1.
8. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL, and the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–60.
9. WHO. Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. Geneva, World Health Organization, 2004.
10. Lawn JE, Cousens S, Zupan J, for the Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: When? Where? Why? Lancet 2005; 365: 891–900.
11. WHO. Neonatal and perinatal mortality. Country, regional and global estimates. Geneva: World Health Organization, 2006.
12. Ross JA, Winfrey WL. Unmet need for contraception in the developing world and the former Soviet Union: an updated estimate. Int Fam Plan Perspect 2002; 28: 138–43.
13. Alan Guttmacher Institute. Sharing responsibility: women, society & abortion. New York: Alan Guttmacher Institute, 1999.
14. WHO. Unsafe abortion. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000. Fourth edition. Geneva: World Health Organization, 2004.
15. WHO. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: World Health Organization, 2001.
16. Rutstein SO, Shah IH. Infecundity, infertility, and childlessness in developing countries. DHS Comparative Reports No.9. Calverton, MD: ORC Macro and Geneva: World Health Organization, 2004.
17. UNAIDS. AIDS epidemic update 2005. Geneva: Joint United Nations Programme on HIV/AIDS and World Health Organization, 2005.
18. Mathers CD, Loncar D. Updated projections of global mortality and disease: 2002-2030. Data sources, methods and results. Geneva: World Health Organization, Evidence and Information for Policy Working Paper, 2005.
19. Garcia-Moreno C, Jansen HAFM, Ellsberg M, Heise L, Watts C. WHO multi-country study on women’s health and domestic violence against women. Initial results on prevalence, health outcomes and women’s responses. Geneva: World Health Organization, 2005.
20. UN Millennium Project. Public choices, private decisions: sexual and reproductive health and the Millennium Development Goals. New York: United Nations Development Programme, 2006.
21. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066–74.
22. WHO. The WHO Reproductive Health Library No.9. Oxford: Update Software, 2006. www.rhlibrary.com (accessed July 5, 2006).
23. World Health Organization. The World Health Report 2005 —Make every mother and child count. Geneva: World Health Organization, 2005.
24. WHO. Skilled attendant at birth—2006 updates. Geneva: World Health Organization, 2006c.
25. The Lancet. The world’s forgotten children. Lancet 2003; 361: 1.
26. Horton R. Newborn survival: putting children at the centre. Lancet 2005; 365: 821–22.
27. Grimes DA, Benson J, Singh S, et al. Unsafe abortion: the preventable pandemic. Lancet 2006; published online Nov 1. DOI:10.1016/S0140-6736(06)69481-6.
28. Berer M. National laws and unsafe abortion: the parameters of change. Reprod Health Matters 2004; 12 (suppl 24): 1–8.
29. Goodwin MM, Gazmararian JA, Johnson CH, Gilbert BC, Saltzman LE. Pregnancy intendedness and physical abuse around the time of pregnancy: fi ndings from the pregnancy risk assessment monitoring system, 1996-1997. PRAMS Working Group. Pregnancy Risk Assessment Monitoring System. Matern Child Health J 2000; 4: 85–92.
30. Over M, Piot P. HIV infection and sexually transmitted diseases. Disease Control Priorities Project 1993 edition. Washington DC: World Bank, 1993.
31. Rowley J, Berkley S. Sexually transmitted diseases. In: Murray CJL, Lopez AD (eds), Health dimensions of sex and reproduction (Global Burden of Disease and Injury Series, Volume III). Cambridge, MA: Harvard University Press, 1998: 19–110.
32. Gerbase AC, Rowley JT, Heymann DHL, Berkley SFB, Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 1998; 74 (suppl 1): S12–16.
33. Anonymous. Introduction. In: Holmes KK, Sparling PF, Mardh PA, et al, eds. Sexually transmitted diseases, 3rd edn. New York: McGraw-Hill, 1999, 21–23.
34. de Sanjose S, Diaz M, Castellsague X, Vimbert R, Tous S, Frayle H, Bosch FX. World-wide cervical HPV prevalence among women without invasive cervical cancer: a review of the literature 1995–2005. 22nd International Papillomavirus Conference, Vancouver, Canada (abstract), 2005.
35. Smith JS, Robinson NJ. Age-specifi c prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186 (suppl): S3–28.
36. Mullick S, Watson-Jones D, Beksinska M, Mabey D. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect 2005; 81: 294–302.
37. Gloyd S, Chai S, Mercer MA. Antenatal syphilis in sub-Saharan Africa: missed opportunities for mortality reduction. Health Policy Plan 2001; 16: 29–34.
38. Schmid G. Economic and programmatic aspects of congenital syphilis prevention. Bull World Health Organ 2004; 82: 1–8.
39. Weinstock H, Berman S, Cates Jr W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36: 6–10.
40. Slaymaker E, Walker N, Zaba B, Collumbien M. Unsafe sex. In: Ezzati, Lopez AD, Rodgers A, Murray CJL, eds. Comparative quantifi cation of health risks: global and regional burden of diseases attributable to selected major risk factors. Geneva: World Health Organization, 2004: 1177–1254.
41. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK. Herpes simplex virus type 2 in the United States, 1976–1994. N Engl J Med 1997; 337: 1105–11.
42. Paz-Bailey G, Rahman M, Chen C, Ballard R, Mo_ at HJ, Kenyon T, Kilmarx PH, Totten PA, Astete S, Boily MC, Ryan C. Changes in STD etiology in Botswana 1993-2002: implications for clinical management of genital ulcer disease. Clin Infect Dis 2005; 41:1304–12.
43. Schmid G, Steen R, Ndowa F. Control of bacterial sexually transmitted diseases in the developing world is possible. Clin Infect Dis 2005; 41: 1313–15.
44. Buve A, Changalucha J, Mayaud P, et al. How many patients with a sexually transmitted infection are cured by health services? A study from Mwanza region, Tanzania. Trop Med Int Health 2001; 6: 971–79.
45. Garnett GP, Bowden FJ. Epidemiology and control of curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis 2000; 27: 588–99.
46. Sami N, Ali TS. Psycho-social consequences of secondary infertility in Karachi. J Pak Med Assoc 2006; 56: 19–22.
47. Latthe PM, Latthe MM, Say L, Gülmezoglu MA, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health 2006; 6: 177.
48. Norton P, Brubaker L. Urinary incontinence in women. Lancet 2006; 367: 57–67.
49. Kamm MA. Faecal incontinence, BMJ 2003; 327: 1299–1300.
50. Population Reference Bureau. Transitions in world population. Popul Bull 2004; 59: 1–40. Washington DC: Population Reference Bureau.
51. Population Reference Bureau. World population data sheet. Washington DC: Population Reference Bureau, 2005.
52. Marston C, Cleland J. Relationships between contraception and abortion: a review of the evidence. Int Fam Plan Perspect 2003; 29:6–13.
53. UN Population Fund. State of the world population 2005. New York: United Nations Population Fund, 2005.
54. Marston C, Cleland J. The e_ ects of contraception on obstetric outcome. Geneva: World Health Organization, 2004: 7–15.
55. Alan Guttmacher Institute. Into a new world: young women’s sexual and reproductive lives. New York: Alan Guttmacher Institute, 1998.
56. Kane R, Wellings K. Reducing the rate of teenage conception. An international review of the evidence: data from Europe. London: Health Education Authority, 1999.
57. Schünmann C, Glasier A. Measuring pregnancy intention and its relationship with contraceptive use amongst women undergoing therapeutic abortion. Contraception 2006; 73: 520–24.
58. Cates W Jr. The NIH Condom Report: the glass is 90% full. Fam Plann Perspect 2001; 33: 231–33.
59. Doncel G, Mauck C. Vaginal microbicides: a novel approach to preventing sexual transmission of HIV. Curr HIV/AIDS Rep 2004; 1:25–32.
60. Cleland J, Sinding S. What would Malthus say about AIDS in Africa? Lancet 2005; 366: 1899–1901.
Traducción y resumen objetivo: Dra. Marta Papponetti. Esp. Medicina Interna. Docente Aut. UBA. Editora Responsable Med. Interna de Intramed.